Hope on the Horizon: What’s Next in Food Allergy
Thursday, October 8, 2026
6:30 p.m. – 8:30 p.m.
Bedford, NY 10506
*Full address to be provided after RSVP in an email confirmation*
About the Event
A conversation about new treatments, promising research—and what it all means for families.
FARE and hosts Hanna and Jon Lamb and Katie and David Geenberg warmly invite you to an intimate, salon-style evening exploring the exciting landscape of food allergy treatment.
As the field continues to rapidly evolve, families are navigating a growing landscape of therapies, medications, and innovations. This evening is designed to provide an accessible and engaging conversation about the latest developments in food allergy care, from promising therapies currently in clinical trials to emerging treatments and newly launched options that are beginning to (re-)shape the future of care.
The evening will feature insights from Dr. Hugh Sampson of the Icahn School of Medicine at Mount Sinai and Dr. Jonathan Hemler of UVA Health, with the conversation moderated by Dr. Stephanie Leeds of Yale School of Medicine. Together, they will explore where the field stands today, what breakthroughs may be on the horizon, the challenges and opportunities that remain, and what families should be watching for in the years ahead.
We hope you will join us for a gathering that promises to be both informative and hopeful, offering a unique “inside look” at the innovations shaping the future of food allergy care.
Featured Speakers and Moderator
Dr. Hugh Sampson
Dr. Hugh Sampson is the Kurt Hirschlorn Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai, Director Emeritus of the Jaffe Food Allergy Institute. Dr. Sampson’s research interests have focused of food allergic disorders, and now include work on the pathogenesis of food-induced anaphylaxis, characterization of allergenic food proteins and their processing by the immune system, genetics of food allergy, development of novel diagnostic tests, and mechanisms of immunotherapeutic strategies for treating food allergies including basic studies and clinical trials in oral, sublingual and epicutaneous immunotherapy and the potential use of biologics, such as anti-IgE and anti-cytokine monoclonal antibodies. His research is funded by a number of grants from the National Institutes of Health, including the recently funded Exposure to Vaginal Microbiome in C-section Infants at Hight-risk for Allergies – A Pilot Study. Dr. Sampson supervises one clinic/week in pediatric allergy and is involved in teaching fellows and residents.
He is an Associate Editor of Pediatric Allergy & Immunology, past president of the American Academy of Allergy, Asthma & Immunology, a member of the National Academy of Medicine, and sits on FARE’s Scientific Advisory Council.
He received his medical degree from University at Buffalo School of Medicine.
Dr. Jonathan Hemler
Dr. Jonathan Hemler is an Associate Professor of Pediatrics and Division Director of Pediatric Allergy, Immunology, & Rheumatology at the University of Virginia School of Medicine. His research focuses on pediatric food allergy therapeutics, the genetics of food allergy, and the management of anaphylaxis, with extensive involvement as a primary investigator in clinical trials for oral and epicutaneous immunotherapies. Dr. Hemler received his medical degree from the University of Virginia School of Medicine, completed his pediatric residency at Children's National Medical Center, and completed his allergy/immunology fellowship at Vanderbilt University Medical Center. He leads clinical trial initiatives within UVA's FARE-designated Discovery Center of Distinction and maintains an active clinical practice supervising pediatric allergy care.
Dr. Stephanie Leeds
Dr. Stephanie Leeds is an Associate Professor of Pediatrics at the Yale School of Medicine and serves as the Principal Investigator for the FARE Clinical Network site at Yale. Her research interests focus on early-onset food allergy, including the natural history, clinical manifestations, novel treatments, and prevention strategies for food allergies in infants and toddlers. She conducts survey-based, clinical, and translational research, with recent studies examining early peanut introduction guidelines, epinephrine underuse in anaphylaxis, and educational challenges in food allergy management. Dr. Leeds completed her medical degree at the University of Chicago, pediatric residency at the Children's Hospital of Philadelphia, and allergy/immunology fellowship at the Icahn School of Medicine at Mount Sinai. She supervises pediatric allergy clinic at Yale New Haven Health and is actively involved in clinical education.